NCT03634982 2022-09-01
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Phase 1 Unknown
Revolution Medicines, Inc.
Silverback Therapeutics
Radboud University Medical Center
Poniard Pharmaceuticals